Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Target 1.21.6 g/kg (about 0.50.7 g/lb) body weight daily
Subcutaneous amounts are community research practices, not an approved clinical protocol
Lets not add BPC-157 to that list by rushing ahead of the evidence
In pre-clinical models, BPC 157 has been observed to: Upregulate vascular endothelial growth factor (VEGF) , promoting new blood vessel formation in damaged tissue Modulate nitric oxide (NO) synthesis pathways, influencing vascular tone and healing cascades Interact with the growth hormone receptor system , potentially amplifying downstream tissue repair signaling Demonstrate cytoprotective effects along the gastrointestinal tract its native home territory as a gastric peptide Exhibit apparent neuroprotective properties in rodent models of CNS injury BPC 157 stability in gastric acid unusual for peptides has made it a focus of GI mucosal repair research
FDAs review repeatedly notes that BPC-157 is used loosely in commerce, while chemical names, salt forms, manufacturing descriptions, analytical standards, and labeling may not consistently identify the same material
